Clinical Research
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 28, 2005; 11(8): 1167-1171
Published online Feb 28, 2005. doi: 10.3748/wjg.v11.i8.1167
Figure 1
Figure 1 Correlation between serum VEGF levels and platelet counts. A: group 1; B: group 2; C: group 3; D: group 4.
Figure 2
Figure 2 VEGF (A), VEGF/PLT (B), and VEGFR1 (C) levels in patients with biliary disease and healthy volunteers. The mean value of each group is presented as a bold line. VEGF/PLT: the calculated parameter by dividing the serum VEGF values (pg/mL) by the platelet counts (×106/mL); Cholangitis: patients with acute cholangitis or cholecystitis; Cancer: patients with biliary neoplasms; PBC/PSC: patients with primary biliary cirrhosis or primary sclerosing cholangitis; normal: healthy volunteers.
Figure 3
Figure 3 Correlation between C-reactive protein (CRP) and VEGF/PLT levels in group 1 (A) and group 2 (B). VEGF/PLT: the calculated parameter by dividing the serum VEGF values (pg/mL) by the platelet counts (×106/mL).
Figure 4
Figure 4 Time course of VEGF/PLT (A and C) and VEGFR1 (B and D) levels in patients with biliary cancer. The levels were measured in each patient before and after the curative operation (A and B) or before and after the progression of cancer in size without any effective treatments (C and D). VEGF/PLT: the calculated parameter by dividing the serum VEGF values (pg/mL) by the platelet counts (×106/mL).